None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Consecutive patients who will be referred to each medical center for EUS-FNB to evaluate pancreatic solid masses 2. Age of 19 or more years old 3. Able to voluntarily agree to participate and to sign informed consent 4. Willingness to participate and sign the informed consent agreement.
Exclusion criteria
Exclusion criteria: 1) if the mass had only a cystic component without a solid component suspected with malignant transformation 2) if the coagulation parameters were abnormal (international normalized ratio >1.5 or platelet count <50,000 cells/cmm 3) postponing the antithrombotic therapy was impossible 4) if the patient had cardiopulmonary instability 5) pregnancy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the proportion of achievement of true diagnosis without ROSE on the first pass | — |
Secondary
| Measure | Time frame |
|---|---|
| the procurement rate of optimal histologic cores (possible for IHC stain);Diagnostic yield: sensitivity, specificity, positive predict value, negative predict value;Rate of technical failure;Procedure/Device related major adverse events | — |
Countries
Korea, Republic of
Contacts
Hallym University Medical Center-Dongtan